Literature DB >> 21375692

Natriuretic peptide metabolism, clearance and degradation.

Lincoln R Potter1.   

Abstract

Atrial natriuretic peptide, B-type natriuretic peptide and C-type natriuretic peptide constitute a family of three structurally related, but genetically distinct, signaling molecules that regulate the cardiovascular, skeletal, nervous, reproductive and other systems by activating transmembrane guanylyl cyclases and elevating intracellular cGMP concentrations. This review broadly discusses the general characteristics of natriuretic peptides and their cognate signaling receptors, and then specifically discusses the tissue-specific metabolism of natriuretic peptides and their degradation by neprilysin, insulin-degrading enzyme, and natriuretic peptide receptor-C.
© 2011 The Author Journal compilation © 2011 FEBS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21375692      PMCID: PMC4495883          DOI: 10.1111/j.1742-4658.2011.08082.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  79 in total

1.  High-affinity enkephalin-degrading peptidase in brain is increased after morphine.

Authors:  B Malfroy; J P Swerts; A Guyon; B P Roques; J C Schwartz
Journal:  Nature       Date:  1978-11-30       Impact factor: 49.962

2.  Pulmonary extraction of immunoreactive atrial natriuretic factor in dogs.

Authors:  E R Bates; M J McGillem; G B Mancini; R J Grekin
Journal:  Am J Cardiol       Date:  1989-02-01       Impact factor: 2.778

3.  Molecular determinants of the clearance function of type C receptors of natriuretic peptides.

Authors:  D Cohen; G Y Koh; L N Nikonova; J G Porter; T Maack
Journal:  J Biol Chem       Date:  1996-04-19       Impact factor: 5.157

4.  Specific receptors for atrial natriuretic polypeptide on basolateral membranes isolated from rat renal cortex.

Authors:  R Hori; K Inui; H Saito; Y Matsukawa; K Okumura; K Nakao; N Morii; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1985-06-28       Impact factor: 3.575

5.  Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.

Authors:  I Kishimoto; F K Hamra; D L Garbers
Journal:  Can J Physiol Pharmacol       Date:  2001-08       Impact factor: 2.273

6.  Cellular mechanisms of the clearance function of type C receptors of atrial natriuretic factor.

Authors:  D R Nussenzveig; J A Lewicki; T Maack
Journal:  J Biol Chem       Date:  1990-12-05       Impact factor: 5.157

7.  The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.

Authors:  N Matsukawa; W J Grzesik; N Takahashi; K N Pandey; S Pang; M Yamauchi; O Smithies
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

8.  Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure.

Authors:  M G Buckley; D Sethi; N D Markandu; G A Sagnella; D R Singer; G A MacGregor
Journal:  Clin Sci (Lond)       Date:  1992-10       Impact factor: 6.124

9.  Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.

Authors:  Candace Y W Lee; Horng H Chen; Ondrej Lisy; Suzanne Swan; Courtney Cannon; Hsiao D Lieu; John C Burnett
Journal:  J Clin Pharmacol       Date:  2009-04-24       Impact factor: 3.126

10.  Metabolism of 125I-atrial natriuretic factor by vascular smooth muscle cells. Evidence for a peptidase that specifically removes the COOH-terminal tripeptide.

Authors:  G R Johnson; L Arik; C J Foster
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

View more
  104 in total

1.  Assessment of Targeted Nanoparticle Assemblies for Atherosclerosis Imaging with Positron Emission Tomography and Potential for Clinical Translation.

Authors:  Yongjian Liu; Hannah P Luehmann; Lisa Detering; Eric D Pressly; Alaina J McGrath; Deborah Sultan; Annie Nguyen; Susannah Grathwohl; Monica Shokeen; Mohamed Zayed; Robert J Gropler; Dana Abendschein; Craig J Hawker; Pamela K Woodard
Journal:  ACS Appl Mater Interfaces       Date:  2019-04-19       Impact factor: 9.229

Review 2.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

Review 3.  Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase.

Authors:  Kunio S Misono; John S Philo; Tsutomu Arakawa; Craig M Ogata; Yue Qiu; Haruo Ogawa; Howard S Young
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

Review 4.  The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms.

Authors:  Kailash N Pandey
Journal:  FEBS J       Date:  2011-04-07       Impact factor: 5.542

Review 5.  Cirrhotic cardiomyopathy: Implications for the perioperative management of liver transplant patients.

Authors:  Suehana Rahman; Susan V Mallett
Journal:  World J Hepatol       Date:  2015-03-27

6.  Bi-allelic Loss-of-Function Mutations in the NPR-C Receptor Result in Enhanced Growth and Connective Tissue Abnormalities.

Authors:  Eveline Boudin; Tjeerd R de Jong; Tim C R Prickett; Bruno Lapauw; Kaatje Toye; Viviane Van Hoof; Ilse Luyckx; Aline Verstraeten; Hugo S A Heymans; Eelco Dulfer; Lut Van Laer; Ian R Berry; Angus Dobbie; Ed Blair; Bart Loeys; Eric A Espiner; Jan M Wit; Wim Van Hul; Peter Houpt; Geert R Mortier
Journal:  Am J Hum Genet       Date:  2018-07-19       Impact factor: 11.025

7.  The mRNA-destabilizing protein Tristetraprolin targets "meiosis arrester" Nppc mRNA in mammalian preovulatory follicles.

Authors:  Guangyin Xi; Lei An; Wenjing Wang; Jing Hao; Qianying Yang; Lizhu Ma; Jinlun Lu; Yue Wang; Wenjuan Wang; Wei Zhao; Juan Liu; Mingyao Yang; Xiaodong Wang; Zhenni Zhang; Chao Zhang; Meiqiang Chu; Yuan Yue; Fusheng Yao; Meijia Zhang; Jianhui Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-01       Impact factor: 11.205

8.  Differential effects of low-dose sacubitril and/or valsartan on renal disease in salt-sensitive hypertension.

Authors:  Iuliia Polina; Mark Domondon; Rebecca Fox; Anastasia V Sudarikova; Miguel Troncoso; Valeriia Y Vasileva; Yuliia Kashyrina; Monika Beck Gooz; Ryan S Schibalski; Kristine Y DeLeon-Pennell; Wayne R Fitzgibbon; Daria V Ilatovskaya
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-28

9.  Hormonal coordination of natriuretic peptide type C and natriuretic peptide receptor 3 expression in mouse granulosa cells.

Authors:  Kyung-Bon Lee; Meijia Zhang; Koji Sugiura; Karen Wigglesworth; Tracy Uliasz; Laurinda A Jaffe; John J Eppig
Journal:  Biol Reprod       Date:  2013-02-21       Impact factor: 4.285

10.  Natriuretic peptide receptor-3 gene (NPR3): nonsynonymous polymorphism results in significant reduction in protein expression because of accelerated degradation.

Authors:  Naveen L Pereira; Dong Lin; Linda Pelleymounter; Irene Moon; Gail Stilling; Bruce W Eckloff; Eric D Wieben; Margaret M Redfield; John C Burnett; Vivien C Yee; Richard M Weinshilboum
Journal:  Circ Cardiovasc Genet       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.